Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (71-80 of 291) with videos related to

Pageof 30
Sort By:
Thrombosis and Haemostasis|August 30, 1983
Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human bloodC Kluft, A F Jie, R A Allen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.
American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.
Thrombosis and Haemostasis|May 1, 1995
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypassM Spannagl, G Dooijewaard, W Dietrich, et al.
Methods in Enzymology|January 1, 1988
Measurement of contact-activation patterns of human plasma samples with synthetic substratesG Dooijewaard, C Kluft, J J van Iersel
Human Molecular Genetics|December 1, 1992
PCR detection of a dinucleotide repeat in the human histidine-rich glycoprotein (HRG) geneB C Hennis, A C Havelaar, C Kluft
Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.
Acta Medica Scandinavica|January 1, 1987
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarctionJ Gram, J Jespersen, C Kluft, et al.
Pageof 30

Showing results (71-80 of 291) with videos related to

Sort By:
Pageof 30
Thrombosis and Haemostasis|August 30, 1983
Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human bloodC Kluft, A F Jie, R A Allen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.
American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.
Thrombosis and Haemostasis|May 1, 1995
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypassM Spannagl, G Dooijewaard, W Dietrich, et al.
Methods in Enzymology|January 1, 1988
Measurement of contact-activation patterns of human plasma samples with synthetic substratesG Dooijewaard, C Kluft, J J van Iersel
Human Molecular Genetics|December 1, 1992
PCR detection of a dinucleotide repeat in the human histidine-rich glycoprotein (HRG) geneB C Hennis, A C Havelaar, C Kluft
Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.
Acta Medica Scandinavica|January 1, 1987
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarctionJ Gram, J Jespersen, C Kluft, et al.
Pageof 30